OTTAWA, Sept 25 (Reuters) - Canada has signed a deal with Cambridge-based AstraZeneca to buy up to 20 million doses of its COVID-19 vaccine candidate, Prime Minister Justin Trudeau told reporters on Friday.
The medication is among the leading candidates in the global race for a vaccine, now in late-stage trials in Britain, South Africa and elsewhere. (Reporting by David Ljunggren)
Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.
Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.